In the US anti-TNF biologics treatments can cost several thousand dollars per month. Even with patents expiring this year the industry isn't expecting dramatic price drops due to the different regulatory process for bio-similars versus a typical generic drug.
I'm sure there are many patients who would be happy for a more cost effective option.
I'm sure there are many patients who would be happy for a more cost effective option.